Fragile X syndrome future or investigational therapies

Fragile X syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Fragile X syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Fragile X syndrome future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Fragile X syndrome future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Fragile X syndrome future or investigational therapies
CDC on Fragile X syndrome future or investigational therapies
Fragile X syndrome future or investigational therapies in the news
Blogs on Fragile X syndrome future or investigational therapies
Directions to Hospitals Treating Fragile X syndrome
Risk calculators and risk factors for Fragile X syndrome future or investigational therapies

There are some medications under trials such as fenobam (mGLUR5 antagonist) and Lithium (mGLUR5 signaling inhibitor).